Back to top
Close
Steve Reitmeister

Don't Buy These Stocks

Dear Zacks.com Visitor,

A company may look good fundamentally, but something is amiss when it is dubbed a Zacks Rank #5 Strong Sell. Overall, stocks with that mathematical rating perform 4 times worse than the market.

That is why I want to give you a free welcome gift from Zacks.com: 220 Stocks to Sell Today.

Make sure none of the stocks you are holding or considering are on that Red Flag list.

Genomic Health Inc: (BATS: GHDX)

(U.S: BATS) As of Jul 31, 2014 11:01 AM ET

 Add to portfolio

 ZacksTrade Now

$25.61 USD

25.61

-0.74 (-2.81%)

Volume: 8,660

Zacks Rank : 3-Hold [?]     3    

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The way to access to the Zacks Rank

Quote Overview

Stock Activity

Open 25.90
Day Low 25.61
Day High 26.28
52 Wk Low 23.90
52 Wk High 37.24
Avg. Volume 150,599
Market Cap 823.23 M
Dividend 0.00 ( 0.00%)
Beta 0.54

Key Earnings Data

Forward PE NA
PEG Ratio NA
Current Qtr Est -0.28
Current Yr Est -0.88
Most Accurate Est -0.24
Qtr Earnings ESP[?] 14.29%
Exp Earnings Date 7/30/14
Prior Year EPS -0.33
Exp EPS Growth 17.45%
Industry MED-BIOMED/GENE

Earnings ESP (Expected Surprise Prediction) is Zacks’ proprietary methodology for determining which stocks have the best chance to surprise with their next earnings announcement.

Read more about this innovative method in the Zacks Earnings ESP Guide See all the top Earnings ESP Stocks.

Premium Research for GHDX

Zacks Rank [?] Hold 3
Zacks Industry Rank 105 / 265 (Top 40%)
Equity Research Report

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1 Strong Buy 26.65%
2 Buy 18.84%
3 Hold 10.45%
4 Sell 4.76%
5 Strong Sell 2.56%
S&P 500 10.28%

Zacks Rank Education - Learn more about the Zacks Rank

Zacks Rank Home - All Zacks Rank resources in one place

Zacks Premium - The only way to get access to the Zacks Rank

( = Change in last 30 days)

View All Zacks Rank #1 Strong Buys

Learn to Profit from the Zacks Rank

Zacks Recommendation has been removed. Learn more

Due to overwhelming customer feedback we have removed the Zacks Recommendation. Unfortunately, having two separate rating systems proved far too confusing to most investors. Going forward we will just focus on the Zacks Rank which has a longer and more impressive track record of outperformance. Even though the Zacks Rank is primarily used for stock trading in a 1-3 month time frame, it also can be very helpful for long term investors. To learn more about using the Zacks Rank for long term investing, click here.

Premium Research : Industry Analysis

Top Peers Symbol Zacks Rank
GENOMIC HEALTH GHDX
ACTELION LTD ALIOF
CELGENE CORP CELG
CURIS INC CRIS
ILLUMINA INC ILMN
AASTROM BIOSCI ASTM
ALEXION PHARMA ALXN
AMICUS THERAPT FOLD
ANTHERA PHARMA ANTH
CHINA BIOLOGIC CBPO

See all MED-BIOMED/GENE Peers>>